JP Morgan Chase’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,000
Closed -$280K 5616
2020
Q2
$280K Sell
20,000
-300,000
-94% -$4.08M ﹤0.01% 4110
2020
Q1
$3.76M Buy
+320,000
New +$4.23M ﹤0.01% 2495
2016
Q3
Sell
-38,700
Closed -$408K 4666
2016
Q2
$408K Sell
38,700
-61,300
-61% -$725K ﹤0.01% 3511
2016
Q1
$1.26M Buy
+100,000
New +$1.1M ﹤0.01% 2955

Other funds holding INVA

JP Morgan Chase's INVA Position: Q1 2026 in Review

JP Morgan Chase increased its Innoviva (INVA) stake by 134% in Q1 2026, buying an estimated $4.32M and bringing the position to 350,571 shares worth $8.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

JP Morgan Chase first reported a position in INVA in Q2 2013 and has held it in 45 quarters since. The position peaked at $15.6M in Q3 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • JP Morgan Chase held 350,571 shares of Innoviva worth $8.03M as of Q1 2026.
  • JP Morgan Chase bought 200,769 Innoviva shares in Q1 2026, an estimated $4.32M.
  • Innoviva made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2882 holding.
  • JP Morgan Chase first reported a position in Innoviva in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Innoviva position peaked at $15.6M in Q3 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.